Status:
RECRUITING
Clinical Characteristics of Infantile Hemangioma
Lead Sponsor:
West China Hospital
Conditions:
Hemangioma
Eligibility:
All Genders
Up to 6 years
Brief Summary
The primary purpose of this study is to identify the clinical characteristics of infantile hemangioma (IH) in our single center in China. The second objective of the study is to identify the clinical ...
Detailed Description
Infantile hemangioma (IH) is the most common benign tumor of infancy with an estimated prevalence of 4%-5%. IHs may be presented in any part of body including the visceral organs, but are preferential...
Eligibility Criteria
Inclusion
- Age ≤6 years old
- Diagnose of IHs
- Consent of both parents (or the person having parental authority in families)
Exclusion
- Congenital hemangioma, kaposiform hemangioendothelioma, or other vascular anomalies
- Age\>6 years
- Hemangioma has been previous treated with corticosteroids, laser, cryotherapy, or only other treatments
- Patients with an inability to participate or to follow the study treatment and assessment plan
Key Trial Info
Start Date :
October 6 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT03331744
Start Date
October 6 2017
End Date
December 1 2025
Last Update
January 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
West China Hospital of Sichuan University
Chengdu, Sichuan, China, 610041